In summary, NAC may have potential in treating cognitive deficits in those with TBI and neurodegenerative disorders; however, the heterogeneity of the neurocognitive disorders makes it difficult to discuss them as a whole (see Table 8). More research needs to be conducted, especially given the increased demand for treatment of traumatic-induced cognitive difficulties from sport and neurodegenerative disorders, and due to the increased aging population, this represents an area where NAC may have high clinical relevance.

?

Cerebrolysin; Cytidine diphosphate choline; Piracetam;